Keywords
18F-fluorodeoxyglucose positron emission tomography-computed tomography
Maximum standardized uptake value
Metabolic tumor volume
Total lesion glycolysis
Prognosis
Submitted : 2024-01-23
Accepted : 2024-02-07
Published : 2024-02-22
Abstract
Objective: To assess the prognostic value of maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) determined by 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) imaging in Hodgkin’s lymphoma patients. Methods: A total of 148 Hodgkin’s lymphoma patients diagnosed with lymph node biopsy from October 2014 to October 2015 were retrospectively analyzed followed by categorizing into good (125 cases) and poor (23 cases) prognosis groups. The chi-squared test was used to analyze the clinicopathological characteristics of Hodgkin’s lymphoma patients with the semi-quantitative 18F-FDG PET/CT parameters; the Spearman method was used to analyze the correlation between the semi-quantitative parameters and clinicopathological features of Hodgkin’s lymphoma; receiver operating characteristic curve was used to analyze the predictive value of the semi-quantitative parameters for poor prognosis of Hodgkin’s lymphoma patients. Results: Mean SUVmax, MTV, and TLG of the 148 cases of Hodgkin’s lymphoma were 7.26 ± 2.38, 12.46 ± 3.14 cm3, and 76.83 ± 18.56 g, respectively. Significant variations in the Ann Arbor stage and clinical classification were observed with different levels of semi-quantitative parameters (P < 0.05). The semi-quantitative parameters were not correlated with age and gender (P > 0.05) but positively correlated with Ann Arbor stage and clinical classification (P < 0.05). These parameters in the poor prognosis group were higher than those in the good prognosis group (P < 0.05). The area under the curve (AUC) of SUVmax, MTV, and TLG in predicting the poor prognosis group was 0.881, 0.875, and 0.838, with cut-off values of 7.264, 12.898 cm3, and 74.580g, as well as specificity of 88.8%, 84.0%, and 78.4%, and sensitivity of 87.0%, 87.0%, and 78.3%, respectively; the AUC of the combined prediction was 0.986, with a specificity of 97.6% and sensitivity of 86.3%. Conclusion: The semi-quantitative 18F-FDG PET/CT parameters provide valuable insights for Hodgkin’s lymphoma prognosis assessment.
References
Xiang CX, Chen ZH, Zhao S, et al., 2019, Laryngeal Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Clinicopathologic Study of 31 Cases in China. Am J Surg Pathol, 43(7): 995–1004. https://doi.org/10.1097/PAS.0000000000001266
Demina EA, Tumyan GS, Moiseeva TN, et al., 2020, Hodgkin’s Lymphoma. Journal of Modern Oncology, 22(2): 6–33. https://doi.org/10.26442/18151434.2020.2.200132
Hu Y, Huang Y, Luo W, et al., 2019, Analysis of Clinical Characteristics and Prognosis of 222 Patients with Hodgkin’s Lymphoma. Chinese Medical Journal, 99(48): 3792–3796.
Ferrando-Castagnetto F, Wakfie-Corieh CG, Alba-María-Blanes-García MD, et al., 2020, Incidental and Simultaneous Finding of Pulmonary Thrombus and COVID-19 Pneumonia in a Cancer Patient Derived to 18F-FDG PET/CT. New Pathophysiological Insights from Hybrid Imaging. Radiol Case Rep, 15(10): 1803–1805. https://doi.org/10.1016/j.radcr.2020.07.032
Zhang J, Liu B, Ruan Q, et al., 2018, Primary Intraspinal Diffuse Large B-Cell Lymphoma 18F-FDG A Case of PET/CT Imaging. Chinese Journal of Nuclear Medicine and Molecular Imaging, 38(5): 355–356.
Jiang Y, Hou G, Zhu Z, et al., 2020, The Value of Multiparameter 18F-FDG PET/CT Imaging in Differentiating Retroperitoneal Paragangliomas from Unicentric Castleman Disease. Sci Rep, 2020, 10(1):12887. https://doi.org/10.1038/s41598-020-69854-7
Huang L, Liu W, 2005, Guidelines for Diagnosis and Treatment of Hodgkin’s Disease. Journal of Emergency and Critical Care Medicine, 11(3): 147.
Dada R, 2018, Program Death Inhibitors in Classical Hodgkin’s Lymphoma: A Comprehensive Review. Ann Hematol,97(1): 555–561. https://doi.org/10.1007/s00277-017-3226-0
Yang Q, Wang P, Wang L, 2019, A case of Hodgkin’s Lymphoma Diagnosed by Thyroid Fine-Needle Aspiration Cytology. Diagnostic Theory and Practice, 18(2): 215–217.
Mussetti A, Sureda A, 2019, Is This Real Life? Is This Just Fantasy? Decreased Relapse Following Haploidentical Transplant in Hodgkin’s Lymphoma with Posttransplant Cyclophosphamide. Bone Marrow Transpl, 55(3): 1–2. https://doi.org/10.1038/s41409-019-0754-3
Albany D, Bosio G, Pagani C, et al., 2019, Prognostic Role of Baseline 18F-FDG PET/CT Metabolic Parameters in Burkitt Lymphoma. Eur J Nucl Med Mol Imaging, 46(1): 87–96. https://doi.org/10.1007/s00259-018-4173-2
Zhao K, Zhu Y, Liu Y, et al., 2020, Diagnostic Evaluation of Non-Small Cell Lung Cancer by 18F-FDG Glucose Metabolism Imaging. Journal of Medical Imaging, 30(1): 52–55.
Mikami T, Ichikawa T, Kazama T, et al., 2020, Cutaneous Metastases from Testicular Diffuse Large B-Cell Malignant Lymphoma and Bowen Disease: 18F-FDG PET/CT Findings. Tokai J Exp Clin Med, 45(2): 58–62.
Cerny M, Dunet V, Rebecchini C, et al., 2019, Response of Locally Advanced Rectal Cancer (LARC) to Radiochemotherapy: DW-MRI and Multiparametric PET/CT in Correlation with Histopathology. Nuklearmedizin, 58(1): 28–38. https://doi.org/10.1055/a-0809-4670
Li Y, Guo Z, Li T, et al., 2020, 18F-FDG PET/CT Imaging Manifestations of Primary Mediastinal Large B-cell Lymphoma. Chinese Journal of Nuclear Medicine and Molecular Imaging, 40(1): 1–5.
Wang C, Li P, Wu S, et al., 2016, The Role of Fluorine-18 Fluorodeoxyglucose PET in Prognosis Evaluation for Stem Cell Transplantation of Lymphoma: A Systematic Review and Meta-Analysis. Nucl Med Commun, 37(4): 338–347. https://doi.org/10.1097/MNM.0000000000000468